A recent study has shown that the current available data on human papillomavirus (HPV) type and cervical cancer incidence do not support the epidemiological claims made by the Programme for Appropriate Technology in Health (PATH) regarding India having a large burden of cervical cancer.
In April 2010, the Indian Council of Medical Research suspended research on the feasibility and safety of HPV vaccine in Andhra Pradesh and Gujarat amid public concerns about its safety. The study was being done for two pharmaceutical companies by PATH and was supported by the ICMR.
Technology Partners: MimirTech
Links:
[1] http://admin.indiaenvironmentportal.org.in/news/path%E2%80%99s-claim-india%E2%80%99s-large-burden-cervical-cancer-faulty-study
[2] http://admin.indiaenvironmentportal.org.in/category/author/aarti-dhar
[3] http://admin.indiaenvironmentportal.org.in/category/newspaper/hindu-new-delhi
[4] http://admin.indiaenvironmentportal.org.in/category/thesaurus/cancer
[5] http://admin.indiaenvironmentportal.org.in/category/thesaurus/indian-council-medical-research-icmr
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/andhra-pradesh
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/gujarat
[8] http://admin.indiaenvironmentportal.org.in/category/thesaurus/vaccination
[9] http://admin.indiaenvironmentportal.org.in/category/thesaurus/ahmedabad-d
[10] http://admin.indiaenvironmentportal.org.in/category/thesaurus/who
[11] http://admin.indiaenvironmentportal.org.in/category/thesaurus/health-effects
[12] http://admin.indiaenvironmentportal.org.in/category/thesaurus/health
